DK1709052T3 - Derivater af 1,4-diazabicyclo 3.2.1octancarboxamid, fremstilling deraf og anvendelse deraf i terapi - Google Patents

Derivater af 1,4-diazabicyclo 3.2.1octancarboxamid, fremstilling deraf og anvendelse deraf i terapi

Info

Publication number
DK1709052T3
DK1709052T3 DK05717375.9T DK05717375T DK1709052T3 DK 1709052 T3 DK1709052 T3 DK 1709052T3 DK 05717375 T DK05717375 T DK 05717375T DK 1709052 T3 DK1709052 T3 DK 1709052T3
Authority
DK
Denmark
Prior art keywords
alkyl
alpha
definitions
diazacyclo
heterocyclylcarbonyl
Prior art date
Application number
DK05717375.9T
Other languages
English (en)
Inventor
Frederic Galli
Odile Leclerc
Alistair Lochead
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1709052T3 publication Critical patent/DK1709052T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
DK05717375.9T 2004-01-16 2005-01-07 Derivater af 1,4-diazabicyclo 3.2.1octancarboxamid, fremstilling deraf og anvendelse deraf i terapi DK1709052T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0400390A FR2865208B1 (fr) 2004-01-16 2004-01-16 Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique
PCT/FR2005/000027 WO2005077955A1 (fr) 2004-01-16 2005-01-07 Derives de 1,4-diazabicyclo[3.2.1]octanecarboxamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
DK1709052T3 true DK1709052T3 (da) 2011-08-15

Family

ID=34707894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05717375.9T DK1709052T3 (da) 2004-01-16 2005-01-07 Derivater af 1,4-diazabicyclo 3.2.1octancarboxamid, fremstilling deraf og anvendelse deraf i terapi

Country Status (27)

Country Link
US (1) US7589201B2 (da)
EP (1) EP1709052B1 (da)
JP (1) JP4781279B2 (da)
KR (1) KR101146445B1 (da)
CN (1) CN1946726B (da)
AT (1) ATE507228T1 (da)
AU (1) AU2005212867B2 (da)
BR (1) BRPI0506879A (da)
CA (1) CA2549954C (da)
CY (1) CY1111707T1 (da)
DE (1) DE602005027659D1 (da)
DK (1) DK1709052T3 (da)
ES (1) ES2365141T3 (da)
FR (1) FR2865208B1 (da)
HK (1) HK1105632A1 (da)
HR (1) HRP20110538T1 (da)
IL (1) IL176702A (da)
MA (1) MA28238A1 (da)
NO (1) NO20063666L (da)
NZ (1) NZ548046A (da)
PL (1) PL1709052T3 (da)
PT (1) PT1709052E (da)
RS (1) RS51910B (da)
RU (1) RU2361873C2 (da)
SI (1) SI1709052T1 (da)
WO (1) WO2005077955A1 (da)
ZA (1) ZA200605823B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005243147A1 (en) * 2004-05-07 2005-11-24 Memory Pharmaceuticals Corporation 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (ja) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するためのチエノピリジン
WO2006124897A2 (en) * 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
JP2009506036A (ja) * 2005-08-24 2009-02-12 レキシコン・ファーマシューティカルズ・インコーポレーテッド ピロロピリジン、ピロロピリミジンおよびピラゾロピリジン化合物、それらを含む組成物、ならびにそれらの使用方法
AR079980A1 (es) * 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
FR2809730B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
WO2003044018A1 (en) * 2001-11-19 2003-05-30 Neurogen Corporation 1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides
US6673811B1 (en) * 2001-11-19 2004-01-06 Neurogen Corporation 1H-pyrrolo [3,2-b] pyridine-3-carboxylic acid amines as GABAA receptor ligands
SE0202465D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
FR2845388B1 (fr) * 2002-10-08 2004-11-12 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
US7456171B2 (en) * 2002-10-08 2008-11-25 Sanofi-Aventis 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof
TW200529860A (en) * 2003-12-22 2005-09-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands

Also Published As

Publication number Publication date
CA2549954A1 (fr) 2005-08-25
CN1946726A (zh) 2007-04-11
PL1709052T3 (pl) 2011-09-30
RU2006129633A (ru) 2008-02-27
AU2005212867B2 (en) 2011-05-12
CY1111707T1 (el) 2015-10-07
JP4781279B2 (ja) 2011-09-28
HK1105632A1 (en) 2008-02-22
KR101146445B1 (ko) 2012-05-18
RU2361873C2 (ru) 2009-07-20
IL176702A (en) 2011-07-31
NO20063666L (no) 2006-10-11
AU2005212867A1 (en) 2005-08-25
US7589201B2 (en) 2009-09-15
ES2365141T3 (es) 2011-09-23
KR20070017990A (ko) 2007-02-13
FR2865208B1 (fr) 2009-01-16
EP1709052A1 (fr) 2006-10-11
WO2005077955A1 (fr) 2005-08-25
CA2549954C (fr) 2013-04-23
NZ548046A (en) 2009-12-24
JP2007517838A (ja) 2007-07-05
PT1709052E (pt) 2011-07-20
ATE507228T1 (de) 2011-05-15
MA28238A1 (fr) 2006-10-02
CN1946726B (zh) 2011-08-31
ZA200605823B (en) 2008-01-08
HRP20110538T1 (hr) 2011-08-31
EP1709052B1 (fr) 2011-04-27
IL176702A0 (en) 2006-10-31
RS51910B (en) 2012-02-29
US20070155749A1 (en) 2007-07-05
SI1709052T1 (sl) 2011-08-31
BRPI0506879A (pt) 2007-06-12
DE602005027659D1 (de) 2011-06-09
FR2865208A1 (fr) 2005-07-22

Similar Documents

Publication Publication Date Title
CY1111707T1 (el) Παραγωγα toy 1,4 διαζαδικυκλο 3.2.1 οκτανοκαρβοξυαμιδιου, η παρασκευη τους και η θεραπευτικη εφαρμογη τους
AR054417A1 (es) Derivados de imidazol. proceso de obtencion y composiciones farmaceuticas.
AR064197A1 (es) Derivados de pirimidina y piridina inhibidores de la proteina quinasa
AR074238A1 (es) Compuesto de n-{[(1r,4s,6r)-3-(2-piridinilcarbonil)-3-azabiciclo[4,1.0]hept-4-il]metil}-2-heteroarilamina, su uso para la preparacion de un medicamento util para el tratamiento de una enfermedad que requiere un antagonista del receptor de orexina humano y composicion farmaceutica que lo comprende
BRPI0707491B8 (pt) compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
AR054184A1 (es) Derivados de 1,5 difenilpirazol. procesos de obtencion y composiciones farmaceuticas.
AR056556A1 (es) Imidazo(1,2-a)piridina con actividad antiproliferacion celular
AR070636A1 (es) Derivados de piridina, composicion farmaceutica y uso terapeutico
RS50755B (sr) Supstituisani aril i heteroaril derivati kao modulatori metabolizma i profilakse i lečenje poremećaja proisteklih iz toga
RS54518B1 (en) Bicyclic Heterocyclic Compounds as Protein Tyrosine Kinase Inhibitors
AR062886A1 (es) Compuestos de tiazol pirazolopirimidina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento
CO5680435A2 (es) Derivados de quinazolina inhibidores de tirosina quinasa erbb y egb, su procedimiento de sintesis y composiciones farmaceuticas que los contienen
RU2012143689A (ru) Спироциклические соединения и их применение в качестве терапевтических агентов и диагностических зондов
HK1110868A1 (en) Heterocyclic compounds as ccr2b antagonists
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
AR049487A1 (es) Compuestos de imidazol sustituidos
EA200870545A1 (ru) Новые гетероциклические соединения
CO5690551A2 (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo
AR063625A1 (es) COMPUESTOS HETEROCICLICOS eTILES COMO AGENTES ANTICANCEROSOS
WO2005118579A3 (en) Thiazole derivatives as chemokine receptor antagonists
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
WO2009044007A3 (fr) Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique
WO2005100322A8 (en) Sulphur-linked imidazole compounds for the treament of hiv
PE20060495A1 (es) 4-(2,4-dicloro-5-metoxifenil)amino-6-metoxi-7-{[5-(amino-sustituido) metil]-3-furil}-3-quinolincarbonitrilos como inhibidores de quinasa